Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy.
CAT No: 10-101-206
CAS No:115150-59-9
Synonyms/Alias:Antagonist G;115150-59-9;(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]-methylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]-4-methylpentanamide;L-Methioninamide, L-arginyl-D-tryptophyl-N-methyl-L-phenylalanyl-D-tryptophyl-L-leucyl-;antagonist-g;RWFWLM;RW-N(Me)F-Wlm-NH2;Arg-trp-N-methyl-phe-trp-leu-met-NH2;H-Arg-D-trp-N(Me)phe-D-trp-leu-met-NH2;an-tagonist g;Antagonist G?;Arginyl-tryptophyl-N-methylphenylalanyl-tryptophyl-leucyl-methioninamide;L-Arginyl-O-tryptophyl-N-methyl-L-phenylalanyl-D-tryptophyl-L-leucyl-L-methioninamide;(Arg6,D-Trp7.9,N-Me-Phe8)-Substance P (6-11);CHEMBL4303227;HY-P1185;MFCD00133831;AKOS024456877;L-Methioninamide, L-arginyl-O-tryptophyl-N-methyl-L-phenylalanyl-D-tryptophyl-L-leucyl-;DA-59542;MS-31778;CS-0028917;ARG-D-TRP-N-ME-PHE-D-TRP-LEU-MET-NH2;G12365;(Arg6,D-Trp7?9,N-Me-Phe8)-Substance P (6-11);BRD-K25863791-001-01-8;(S)-N-((5S,8S,11R,14S,17R)-11-((1H-indol-3-yl)methyl)-14-benzyl-5-carbamoyl-18-(1H-indol-3-yl)-8-isobutyl-15-methyl-7,10,13,16-tetraoxo-2-thia-6,9,12,15-tetraazaoctadecan-17-yl)-2-amino-5-guanidinopentanamide;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.